Pfizer: From pandemic hero to investor jitters

Published on December 14, 2023

Pfizer's transitions from pandemic success to market concerns: analyzing revenue stagnation, investor reactions, and the company's strategic roadmap for growth.

Continue reading on website
Other news

Stockholm-based FineCell raises €1 million to produce dry cellulose biomaterials for beauty and healthcare products

December 14, 2023
Swedish startup FineCell (FineCellOx AB), developer of the FineCell technology and producer of CellOx dry cellulose powder, announced it has raised €1 million from Metsä Spring, Metsä Group’s innovation company. Metsä Spring leads a group of investors, including EIT InnoEnergy and the company’s founder. The funds will be used to further develop and plan a… This content is for members only. Visit t

I'm an Economist — You Need to Ask These Questions About Your Business as You Look Toward 2024.

December 14, 2023
Executives: Use these three questions as a check-up on your business heading into an uncertain future.